Results for tag: "Parasympathomimetic Cholinergic Drug"

The Parasympathomimetic Cholinergic Drug market is a subset of the Central Nervous System Drugs market. These drugs are used to treat a variety of conditions, including glaucoma, myasthenia gravis, and Alzheimer's disease. They work by stimulating the parasympathetic nervous system, which is responsible for controlling involuntary body functions such as digestion, heart rate, and respiration. Parasympathomimetic Cholinergic Drugs are typically administered orally, intravenously, or intramuscularly. Common side effects include nausea, vomiting, and diarrhea. Some companies in the Parasympathomimetic Cholinergic Drug market include Allergan, Novartis, Merck, and Pfizer. Show Less Read more